Cargando…

NAFLD as a risk factor for HCC: new rules of engagement?

Detalles Bibliográficos
Autores principales:	Masuzaki, Ryota, Karp, Seth J., Omata, Masao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939149/ https://www.ncbi.nlm.nih.gov/pubmed/27146835 http://dx.doi.org/10.1007/s12072-016-9731-8

Ejemplares similares

NAFLD-Associated HCC: Progress and Opportunities
por: Geh, Daniel, et al.
Publicado: (2021)

Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion
por: Zhang, Chunye, et al.
Publicado: (2021)

HCC, diet and metabolic factors: Diet and HCC
por: Montella, Maurizio, et al.
Publicado: (2011)

PPARs and Mitochondrial Metabolism: From NAFLD to HCC
por: Mello, Tommaso, et al.
Publicado: (2016)

The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
por: Song, Qian, et al.
Publicado: (2022)

Risk Factors for Colorectal Adenoma – Acknowledging the Burden of NAFLD
por: Duvnjak, Marko, et al.
Publicado: (2019)

A PDCD1 Role in the Genetic Predisposition to NAFLD-HCC?
por: Eldafashi, Nardeen, et al.
Publicado: (2021)

NAFLD/MAFLD: New Evidence
por: Mantovani, Alessandro, et al.
Publicado: (2023)

Liver Cancer: Improving Standard Diagnosis and Therapy
por: Masuzaki, Ryota
Publicado: (2023)

NAFLD and MAFLD as emerging causes of HCC: A populational study
por: Myers, Shuna, et al.
Publicado: (2021)

Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma
por: Kanda, Tatsuo, et al.
Publicado: (2020)

Resection of NAFLD-Associated HCC: Patient Selection and Reported Outcomes
por: Campani, Claudia, et al.
Publicado: (2020)

NAFLD-Related HCC: Focus on the Latest Relevant Preclinical Models
por: Fang, Jing, et al.
Publicado: (2023)

NAFLD: Is There Anything New under the Sun?
por: Lonardo, Amedeo, et al.
Publicado: (2017)

Ten simple rules for engaging with artificial intelligence in biomedicine
por: Malik, Avni, et al.
Publicado: (2021)

Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC
por: Longo, Miriam, et al.
Publicado: (2021)

The Role of Stem Cell Factor, Epidermal Growth Factor and Angiopoietin-2 in HBV, HCV, HCC and NAFLD
por: Radmanić, Leona, et al.
Publicado: (2022)

Ten simple rules on how to develop a stakeholder engagement plan
por: Hollmann, Susanne, et al.
Publicado: (2022)

Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies
por: Pal Chaudhary, Surendra, et al.
Publicado: (2023)

Frequency, Risk Factors and Survival Associated with an Intrasubsegmental Recurrence after Radiofrequency Ablation for Hepatocellular Carcinoma
por: Tateishi, Ryosuke, et al.
Publicado: (2013)

Functional Implications of Biochemical and Molecular Characteristics of Donation After Circulatory Death Livers
por: Masuzaki, Ryota, et al.
Publicado: (2015)

The Role of Oxidative Stress in NAFLD–NASH–HCC Transition—Focus on NADPH Oxidases
por: Gabbia, Daniela, et al.
Publicado: (2021)

Hepatocellular carcinoma: HCC
por: Blum, Hubert E.
Publicado: (2011)

Intratumor heterogeneity in HCC
por: Friemel, Juliane, et al.
Publicado: (2015)

Recent Developments in NAFLD
por: Mantovani, Alessandro, et al.
Publicado: (2022)

Rules of engagement
por: Williams, Kim
Publicado: (2014)

Donafenib in Chinese patients with advanced hepatocellular carcinoma (HCC): Really a new standard of care, or should we change paradigm for drug development in HCC?
por: Negri, Francesca, et al.
Publicado: (2021)

Recent updates on the role of the gut-liver axis in the pathogenesis of NAFLD/NASH, HCC, and beyond
por: Ohtani, Naoko, et al.
Publicado: (2023)

Impact factor, Associate Editors, acknowledgements and new editorial rules
por: Santos, Carlos F.
Publicado: (2011)

Molecular network of HCC aggressiveness
por: Kim, Sang Geon, et al.
Publicado: (2015)

Strategies for HCC target discovery
por: Molina-Sánchez, Pedro, et al.
Publicado: (2017)

Human Hepatocellular Carcinoma (HCC)
por: Buonaguro, Luigi
Publicado: (2020)

Incapacitated Capicua in Sorafenib-Resistant HCC
por: Yin, Dingzi, et al.
Publicado: (2020)

NAFLD - A rising metabolic disease
por: Zeigerer, Anja
Publicado: (2021)

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

Lean NAFLD: A not so benign condition?
por: VanWagner, Lisa B., et al.
Publicado: (2018)

Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC
por: Kim, Hyunmi, et al.
Publicado: (2021)

The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC
por: Rusu, Ioana, et al.
Publicado: (2022)

HIF2α Activation in NASH: A New Force Pushing Toward HCC
por: Clavería-Cabello, Alex, et al.
Publicado: (2021)

Molecular Mechanisms of NAFLD in Metabolic Syndrome
por: Martins, Maria João, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8i44qsshal9do5j7iihhulv0c8